• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRINGY JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRINGY JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 20073770
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nodule (4551)
Date of Event 06/08/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported injecting a patient in the jawline with juvéderm® volux¿ xc.A week later, the patient reported ¿pain and lump¿ on their mandible that felt ¿jules root canal.¿ the patient was treated with augmentin for 10 days and a medrol dosepak.There was concern that ¿filler got into the gland or a possible delayed onset inflammatory state.¿ event was ongoing.
 
Event or Problem Description
Additionally, the healthcare professional reported injecting the patient with one syringe of juvéderm® volux¿ xc.The event began 11 days later.The patient was treated with doxycycline and hylenex a month post-onset.
 
Additional Manufacturer Narrative
Additional, corrected, and/or changed data: a2, b3, b5, c1, c3, d1, d4, d6a, h4, h6, h8.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUX XC 2 X 1ML
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key25610771
Report Number3005113652-2026-00640
Device Sequence Number21310885
Product Code LMH
UDI-Device Identifier10840228300073
UDI-Public(01)10840228300073(17)260621(10)1002350366
Combination Product (Y/N)Y
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P110033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse Practitioner
Type of Report Initial,Followup
Report Date (Section B) 07/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/21/2026
Device Catalogue Number20073770
Device Lot Number1002350366
Was Device Available for Evaluation? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 06/16/2026
Supplement Date Received by Manufacturer07/07/2026
Initial Report FDA Received Date06/24/2026
Supplement Report FDA Received Date07/15/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/21/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age56 YR
Patient SexFemale
-
-